US 10213445
Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer
granted A61KA61K31/138A61K31/655
Quick answer
US patent 10213445 (Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/138, A61K31/655, A61K47/54, A61K47/542